ZA87331B - Transdermal formulations - Google Patents

Transdermal formulations

Info

Publication number
ZA87331B
ZA87331B ZA87331A ZA87331A ZA87331B ZA 87331 B ZA87331 B ZA 87331B ZA 87331 A ZA87331 A ZA 87331A ZA 87331 A ZA87331 A ZA 87331A ZA 87331 B ZA87331 B ZA 87331B
Authority
ZA
South Africa
Prior art keywords
transdermal formulations
transdermal
formulations
Prior art date
Application number
ZA87331A
Other languages
English (en)
Inventor
Majid Mahjour
Russell U Nesbitt Jr
Mahdi B Fawzi
Bernadette Tedeschi
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ZA87331B publication Critical patent/ZA87331B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA87331A 1986-02-27 1987-01-16 Transdermal formulations ZA87331B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/833,926 US4666926A (en) 1986-02-27 1986-02-27 Transdermal formulations

Publications (1)

Publication Number Publication Date
ZA87331B true ZA87331B (en) 1987-08-26

Family

ID=25265634

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA87331A ZA87331B (en) 1986-02-27 1987-01-16 Transdermal formulations

Country Status (6)

Country Link
US (1) US4666926A (xx)
EP (1) EP0239527A3 (xx)
JP (1) JPS62205022A (xx)
AU (1) AU592851B2 (xx)
DK (1) DK100087A (xx)
ZA (1) ZA87331B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232934A (en) * 1992-07-17 1993-08-03 Warner-Lambert Co. Method for the treatment of psychomotor stimulant addiction
US5601839A (en) * 1995-04-26 1997-02-11 Theratech, Inc. Triacetin as a penetration enhancer for transdermal delivery of a basic drug
KR101272437B1 (ko) * 2013-01-15 2013-06-10 황은분 엘이디 조명등
WO2017030889A1 (en) 2015-08-14 2017-02-23 Board Of Trustees Of Michigan State University Ionization detector of a coil of a spark plug by shorting the primary inductance

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3846553A (en) * 1969-12-03 1974-11-05 Merck & Co Inc 3-substituted-2-pyridones in the treatment of pain, fever or inflammation
US4061756A (en) * 1976-12-17 1977-12-06 Parke, Davis & Company Methods for treating cardiovascular disorders
US4128555A (en) * 1976-12-17 1978-12-05 Warner-Lambert Company 3-Phenoxypyridine monosulfate and a method for its production
US4067983A (en) * 1976-12-17 1978-01-10 Parke, Davis & Company Pharmaceutical compositions and methods
US4434169A (en) * 1983-01-03 1984-02-28 Warner-Lambert Company Pharmaceutical compositions and methods
IL72684A (en) * 1984-08-14 1989-02-28 Israel State Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment

Also Published As

Publication number Publication date
JPS62205022A (ja) 1987-09-09
EP0239527A3 (en) 1988-01-07
DK100087D0 (da) 1987-02-26
AU6913287A (en) 1987-09-03
AU592851B2 (en) 1990-01-25
DK100087A (da) 1987-08-28
EP0239527A2 (en) 1987-09-30
US4666926A (en) 1987-05-19

Similar Documents

Publication Publication Date Title
GB8606468D0 (en) Therapeutic compositions
PT85458A (en) Transdermal compositions
ZA87331B (en) Transdermal formulations
GB8603733D0 (en) Implement
GB8611808D0 (en) Occlusal bite-check
CS101186A1 (en) Zarizeni zimni ochrany mokre chladici veze s prirozenym tahem vzduchu
GB8606755D0 (en) Formulations
GB8606455D0 (en) Formulations
AU99800S (en) Spatula
AU98258S (en) Spatula
GB8621019D0 (en) Formulation
GB8628604D0 (en) Formulation
GB8621018D0 (en) Formulation
GB8621448D0 (en) Formulation
GB8606259D0 (en) Formulation
GB8621228D0 (en) Formulation
GB8614980D0 (en) Formulation
GB8606403D0 (en) Formulation
GB8624268D0 (en) Formulation
GB8628603D0 (en) Formulation
GB8630907D0 (en) Formulation
GB2196223B (en) Hoe
AU97395S (en) Implement
PH27242A (en) Long acting formulation
ZA87668B (en) Long acting formulation